Ataxia with loss of Purkinje cells in a mouse model for Refsum disease
- PMID: 19004801
- PMCID: PMC2584743
- DOI: 10.1073/pnas.0806066105
Ataxia with loss of Purkinje cells in a mouse model for Refsum disease
Abstract
Refsum disease is caused by a deficiency of phytanoyl-CoA hydroxylase (PHYH), the first enzyme of the peroxisomal alpha-oxidation system, resulting in the accumulation of the branched-chain fatty acid phytanic acid. The main clinical symptoms are polyneuropathy, cerebellar ataxia, and retinitis pigmentosa. To study the pathogenesis of Refsum disease, we generated and characterized a Phyh knockout mouse. We studied the pathological effects of phytanic acid accumulation in Phyh(-/-) mice fed a diet supplemented with phytol, the precursor of phytanic acid. Phytanic acid accumulation caused a reduction in body weight, hepatic steatosis, and testicular atrophy with loss of spermatogonia. Phenotype assessment using the SHIRPA protocol and subsequent automated gait analysis using the CatWalk system revealed unsteady gait with strongly reduced paw print area for both fore- and hindpaws and reduced base of support for the hindpaws. Histochemical analyses in the CNS showed astrocytosis and up-regulation of calcium-binding proteins. In addition, a loss of Purkinje cells in the cerebellum was observed. No demyelination was present in the CNS. Motor nerve conduction velocity measurements revealed a peripheral neuropathy. Our results show that, in the mouse, high phytanic acid levels cause a peripheral neuropathy and ataxia with loss of Purkinje cells. These findings provide important insights in the pathophysiology of Refsum disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene.Nat Genet. 1997 Oct;17(2):190-3. doi: 10.1038/ng1097-190. Nat Genet. 1997. PMID: 9326940
-
Identification of PEX7 as the second gene involved in Refsum disease.Am J Hum Genet. 2003 Feb;72(2):471-7. doi: 10.1086/346093. Epub 2003 Jan 9. Am J Hum Genet. 2003. PMID: 12522768 Free PMC article.
-
Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?J Lipid Res. 2003 Dec;44(12):2349-55. doi: 10.1194/jlr.M300230-JLR200. Epub 2003 Aug 16. J Lipid Res. 2003. PMID: 12923223
-
Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).Hum Mutat. 2004 Mar;23(3):209-18. doi: 10.1002/humu.10315. Hum Mutat. 2004. PMID: 14974078 Review.
-
Phytanic acid storage disease (Refsum's disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management.J Clin Apher. 1999;14(4):181-4. doi: 10.1002/(sici)1098-1101(1999)14:4<181::aid-jca5>3.0.co;2-z. J Clin Apher. 1999. PMID: 10611628 Review.
Cited by
-
Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity.Int J Mol Sci. 2021 Apr 15;22(8):4101. doi: 10.3390/ijms22084101. Int J Mol Sci. 2021. PMID: 33921065 Free PMC article. Review.
-
Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.PLoS One. 2011;6(12):e28539. doi: 10.1371/journal.pone.0028539. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22163031 Free PMC article.
-
Pregnancy outcome in Refsum disease: Affected fetuses and children born to an affected mother.JIMD Rep. 2019 Mar 14;46(1):11-15. doi: 10.1002/jmd2.12020. eCollection 2019 Mar. JIMD Rep. 2019. PMID: 31240149 Free PMC article.
-
Peroxisomes in brain development and function.Biochim Biophys Acta. 2016 May;1863(5):934-55. doi: 10.1016/j.bbamcr.2015.12.005. Epub 2015 Dec 11. Biochim Biophys Acta. 2016. PMID: 26686055 Free PMC article. Review.
-
Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.Mol Cell Biochem. 2012 Jul;366(1-2):335-43. doi: 10.1007/s11010-012-1311-1. Epub 2012 Apr 15. Mol Cell Biochem. 2012. PMID: 22527938
References
-
- Wanders RJA, Jakobs C, Skjeldal OH. In: The Molecular and Metabolic Bases of Disease. Scriver CR, Beaudet AL., Sly WS, Valle D, editors. New York: McGraw–Hill; 2001. pp. 3303–3321.
-
- Jansen GA, Waterham HR, Wanders RJ. Molecular basis of Refsum disease: Sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7) Hum Mutat. 2004;23:209–218. - PubMed
-
- Wierzbicki AS, et al. Refsum's disease: A peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem. 2002;80:727–735. - PubMed
-
- Eldjarn L, et al. Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet. 1966;287:691–693. - PubMed
-
- Gibberd FB, Billimoria JD, Page NG, Retsas S. Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma-exchange. Lancet. 1979;313:575–578. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases